The solution

Clinical intake infrastructure designed around professional control.

CelestyxAI is being developed for the intake and pre-assessment layer that precedes formal clinical evaluation. Its role is to help healthcare teams capture, structure and review relevant information more consistently — without delegating clinical authority to a generative model.

Current positioning

Professional-facing decision-support infrastructure. Not a patient-facing autonomous triage service and not an autonomous diagnostic system.

Workflow concept

Support the intake process before the clinical assessment.

01

Capture

Collect presenting information in a structured workflow adapted to the operational context.

02

Normalize

Convert free-text and structured inputs into a consistent representation that can be inspected and reused.

03

Apply safeguards

Run deterministic policy logic for defined safety-critical rules, exclusions, escalation criteria and workflow constraints.

04

Assist

Use a bounded language-model layer for synthesis, contextual assistance and structured drafting within predefined limits.

05

Validate

Present the result to the appropriate professional for confirmation, correction or rejection.

06

Trace

Preserve the relevant rule, model, prompt, output and validation context required for auditability.

Why this layer matters

Clinical intake is both informational and operational.

Before a formal assessment can occur, teams often need to obtain, organize and prioritize incomplete information. CelestyxAI is focused on making that layer more structured, reviewable and interoperable while preserving the professional workflow around it.

ConsistencyReduce avoidable variation in how intake information is captured and presented.
TraceabilityMake the reasoning context and applied safeguards inspectable rather than opaque.
Human oversightKeep professional validation explicit instead of treating model output as a final clinical decision.
Integration readinessStructure information with downstream clinical systems and FHIR-oriented exchange in mind.
What we are not claiming

Validation comes before efficacy claims.

No autonomous diagnosis

CelestyxAI is not positioned as an independent diagnostic or treatment system.

No proven clinical outcome claim

The current stage is pre-pilot. Prospective clinical performance and outcome benefits have not yet been established.

No direct patient deployment

The current product direction is professional-facing and intended for supervised institutional workflows.

Explore further

Review the safety architecture and validation strategy.